Search by Drug Name or NDC
NDC 13845-1201-03 CYCLOSERINE 250 mg/250mg Details
CYCLOSERINE 250 mg/250mg
CYCLOSERINE is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Parsolex Gmp Center, Inc.. The primary component is CYCLOSERINE.
Product Information
NDC | 13845-1201 |
---|---|
Product ID | 13845-1201_f2a0c59a-f966-50f8-e053-2995a90a9cc1 |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | CYCLOSERINE |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | CYCLOSERINE |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | CAPSULE |
Route | ORAL |
Active Ingredient Strength | 250 |
Active Ingredient Units | mg/250mg |
Substance Name | CYCLOSERINE |
Labeler Name | Parsolex Gmp Center, Inc. |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA060593 |
Listing Certified Through | 2024-12-31 |
Package
NDC 13845-1201-03 (13845120103)
NDC Package Code | 13845-1201-3 |
---|---|
Billing NDC | 13845120103 |
Package | 40 CAPSULE in 1 BOTTLE (13845-1201-3) / 250 mg in 1 CAPSULE (13845-1201-1) |
Marketing Start Date | 2009-03-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |